Lot release testing is essential to assess the purity, potency and identity of biological agents and is a critical part of ensuring drug quality and safety. Regulators such as the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA) require a series of tests on unprocessed and purified bulk materials for each batch of biopharmaceutical production
Lot release testing is conducted at all stages of drug development:
Creative Biolabs offers a wide range of safety and quality testing services for a variety of biopharmaceutical products. All tests performed are fully validated and meet global regulatory requirements such as FDA, EMA and PMDA. Our experienced scientists can design a lot of release plans based on the characteristics of your biopharmaceutical products, or adapt an existing plan to meet your requirements.
Creative Biolabs provides our customers with a full range of service pipelines, from biosafety analysis to stability studies and to the determination of purity, identity and sterility of biopharmaceutical products. Our commitment is to provide one-stop contract services to all customers and to minimize product release time.
To find out more about our lot release testing services, please contact us.
For Research Use Only | Not For Clinical Use